{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:13:54Z","timestamp":1762161234340},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijcard.2017.01.042","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T12:32:42Z","timestamp":1483705962000},"page":"121-126","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Anticoagulant bridging in left-sided mechanical heart valve patients"],"prefix":"10.1016","volume":"232","author":[{"given":"E.A.","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Meijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Riezebos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Tanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.P.","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Hindori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.J.","family":"Chamuleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.01.042_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1378\/chest.102.4_Supplement.445S","article-title":"Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves","volume":"102","author":"Stein","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM199608083350607","article-title":"Prosthetic heart valves","volume":"335","author":"Vongpatanasin","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0020","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates","volume":"126","author":"Siegal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists the seventh ACCP conference on antithrombotic and thrombolytic","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0030","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMra1206531","article-title":"Management of antithrombotic therapy in patients undergoing invasive procedures","volume":"368","author":"Baron","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0035","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0040","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0045","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012) the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0050","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11239-011-0621-6","article-title":"Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study","volume":"32","author":"Kaeberich","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0060","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1016\/j.ijcard.2013.08.010","article-title":"Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients","volume":"168","author":"Attaya","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjcard.2003.10.060","article-title":"Cost analysis of \u2018bridging therapy\u2019 with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation","volume":"93","author":"Amorosi","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-5273(98)00315-5","article-title":"Activated partial thromboplastin time (aPTT) monitoring to achieve therapeutic anticoagulation before and after introducing a nomogram for adjunctive heparin treatment with thrombolytic therapy for acute myocardial infarction","volume":"67","author":"Chamuleau","year":"1998","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/hrt.80.1.35","article-title":"Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study","volume":"80","author":"Chamuleau","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0080","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0090","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0095","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0100","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1182\/blood-2012-06-415943","article-title":"How I treat anticoagulated patients undergoing an elective procedure or surgery","volume":"120","author":"Spyropoulos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11239-015-1216-4","article-title":"Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves","volume":"40","author":"Schulman","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0110","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/CIRCULATIONAHA.108.823211","article-title":"Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study","volume":"119","author":"Pengo","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.thromres.2009.01.011","article-title":"Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients","volume":"124","author":"Daniels","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0120","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2009.06.065","article-title":"Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation","volume":"104","author":"Bui","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.amjcard.2008.05.042","article-title":"Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN registry)","volume":"102","author":"Spyropoulos","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.01.042_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-005-3120-9","article-title":"Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol","volume":"20","author":"Jaffer","year":"2005","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1592\/phco.24.6.649.34740","article-title":"A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation","volume":"24","author":"Spyropoulos","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0140","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","article-title":"Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin","volume":"110","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.89.5.527","article-title":"Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol","volume":"89","author":"Ferreira","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2017.01.042_bb0150","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","author":"Douketis","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317300748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317300748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:57:23Z","timestamp":1536119843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317300748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":30,"alternative-id":["S0167527317300748"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.042","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulant bridging in left-sided mechanical heart valve patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}